Active ingredientPolmacoxibCat. No. P-P152-001CAS 301692-76-2Family · Pharmaceutical analytical standards
Polmacoxib
A non-steroidal anti-inflammatory drug that inhibits COX-2 and also binds carbonic anhydrase, approved in South Korea in 2015 for the treatment of osteoarthritis. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?In the blood it concentrates in red blood cells, bound to carbonic anhydrase, which carry it in an inactive form; in inflamed joints, where this enzyme is scarce and COX-2 is abundant, it blocks inflammation.
Go to the active ingredient →Active ingredientPolmacoxibCat. No. P-P152-001CAS 301692-76-2
Isotopically labelledPolmacoxib-d6Cat. No. P-P152-002
ImpurityPolmacoxib 2-Fluoro ImpurityCat. No. P-P152-003CAS 301693-28-7
ImpurityPolmacoxib Impurity 1Cat. No. P-P152-004
ImpurityPolmacoxib Impurity 2Cat. No. P-P152-005
ImpurityPolmacoxib Impurity 3 Sodium SaltCat. No. P-P152-006CAS 1778703-67-5
ImpurityPolmacoxib Impurity 4Cat. No. P-P152-007
ImpurityPolmacoxib Impurity 5Cat. No. P-P152-008
ImpurityPolmacoxib Impurity 6Cat. No. P-P152-009
ImpurityPolmacoxib Methylthio ImpurityCat. No. P-P152-010CAS 301693-50-5
ImpurityPolmacoxib Sulfonyl ImpurityCat. No. P-P152-012CAS 301690-25-5
ImpurityPolmacoxib Sulfonyl Methyl Acetate ImpurityCat. No. P-P152-013CAS 1778703-66-4
ImpurityPolmacoxib Sulfoxide ImpurityCat. No. P-P152-014CAS 301693-70-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.